Sawynok J, Sweeney M I, White T D
Br J Pharmacol. 1986 Aug;88(4):923-30. doi: 10.1111/j.1476-5381.1986.tb16267.x.
Analogues of adenosine were injected intrathecally into rats implanted with chronic indwelling cannulae in order to determine a rank order of potency and hence characterize adenosine receptors involved in spinal antinociception. In the tail flick test L-N6-phenylisopropyl adenosine (L-PIA), cyclohexyladenosine (CHA) and 5'-N-ethylcarboxamide adenosine (NECA) produced dose-related antinociception which attained a plateau level. NECA and CHA also produced an additional distinct second phase of antinociception. D-N6-Phenylisopropyl adenosine (D-PIA) and 2-chloroadenosine (CADO) had very little antinociceptive activity in this test. The rank order of potency in producing the plateau effect was L-PIA greater than CHA greater than NECA greater than D-PIA = CADO, while that for the second phase of antinociception was NECA greater than-CHA. Pretreatment with both theophylline and 8-phenyltheophylline (8-PT) antagonized antinociception produced by CHA, with 8-PT being at least an order of magnitude more potent than theophylline. Both antagonists produced a significant hyperalgesia in the tail flick test. L-PIA and CHA also produced methylxanthine-sensitive antinociception in the hot plate test. These results suggest that activation of A1-receptors in the spinal cord can produce antinociception. Activation of A2-receptors may produce an additional effect, but the relative activity of CHA in this component of activity is unusual.
将腺苷类似物鞘内注射到植入慢性留置套管的大鼠体内,以确定其效价顺序,从而表征参与脊髓镇痛的腺苷受体。在甩尾试验中,L-N6-苯基异丙基腺苷(L-PIA)、环己基腺苷(CHA)和5'-N-乙基羧酰胺腺苷(NECA)产生剂量相关的镇痛作用,并达到平台水平。NECA和CHA还产生了另一个明显的第二阶段镇痛作用。D-N6-苯基异丙基腺苷(D-PIA)和2-氯腺苷(CADO)在该试验中几乎没有镇痛活性。产生平台效应的效价顺序为L-PIA>CHA>NECA>D-PIA = CADO,而镇痛第二阶段的效价顺序为NECA>CHA。用茶碱和8-苯基茶碱(8-PT)预处理可拮抗CHA产生的镇痛作用,8-PT的效力至少比茶碱高一个数量级。两种拮抗剂在甩尾试验中均产生显著的痛觉过敏。L-PIA和CHA在热板试验中也产生对甲基黄嘌呤敏感的镇痛作用。这些结果表明,脊髓中A1受体的激活可产生镇痛作用。A2受体的激活可能产生额外的作用,但CHA在该活性成分中的相对活性并不寻常。